European surveillance of Clostridioides (Clostridium) difficile infections - surveillance protocol version 2.4
ECDC publishes a protocol developed for the surveillance of Clostridioides (Clostridium) difficile infections (CDI) to address the lack of standardised surveillance of CDI in EU Member States.
Surveillance systems overview for 2018
This spreadsheet contains all surveillance system overview tables from ECDC's annual epidemiological report for 2018.
- Chikungunya virus disease
- Chlamydia infection
- Crimean-Congo haemorrhagic fever
- Ebola haemorrhagic fever
- Hantavirus infection
- Healthcare-associated infections
- Hepatitis A
- Hepatitis B
- Hepatitis C
- HIV infection
- Invasive Haemophilus influenzae disease
- Lassa fever
- Marburg haemorrhagic fever
- Meningococcal disease
- Pneumococcal disease
- Q fever
- Rift Valley fever
- Severe acute respiratory syndrome (SARS)
- Verotoxigenic Escherichia coli infection
- West Nile virus infection
Healthcare-associated infections: surgical site infections - Annual Epidemiological Report for 2017
In 2017, 10 149 SSIs were reported from a total of 648 512 surgical procedures.
Healthcare-associated infections in intensive care units - Annual Epidemiological Report for 2017
In 2017, 8.3% (11 787) of the patients who stayed in intensive-care units (ICUs) for more than two days presented with at least one ICU-acquired healthcare-associated infection (HAI) under surveillance (pneumonia, bloodstream infection, or urinary tract infection).
Strong correlation between the rates of intrinsically antibiotic-resistant species and the rates of acquired resistance in Gram-negative species causing bacteraemia, EU/EEA, 2016
Jarlier, V., Diaz Högberg, L., Heuer, O.E., Campos, J., Eckmanns, T., Giske, C.G., Grundmann, H., Johnson, A.P., Kahlmeter, G., Monen, J., Pantosti, A., Rossolini, G.M., van de Sande-Bruinsma, N., Vatopoulos, A., Żabicka, D., Žemličková, H., Monnet, D.L., Simonsen, G.S., Ears-Net Participants
Privacy Statement - Processing of personal data for the survey of carbapenem- and/or colistin-resistant Enterobacteriaceae
Data are processed for the conduct of the carbapenem- and/or colistin-resistant Enterobacteriaceae (CCRE) survey as part of molecular surveillance of antimicrobial resistant pathogens according to a protocol. For the CCRE survey bacterial isolates (carbapenem and/or colistin-resistant Enterobacteriaceae and susceptible control isolates) and related patient data are collected in hospitals in 37 countries with the aim to determine transmission pathways and improve control measures.
Targets for the reduction of antibiotic use in humans in the Transatlantic Taskforce on Antimicrobial Resistance (TATFAR) partner countries
D'Atri, F., Arthur, J., Blix, H.S., Hicks, L.A., Plachouras, D., Monnet, D.L., The European Survey On Transatlantic Task Force On Antimicrobial Resistance Tatfar Action Group
Resistance proportions for eight priority antibiotic-bacterium combinations in OECD, EU/EEA and G20 countries 2000 to 2030: a modelling study
Cravo Oliveira Hashiguchi, T., Ait Ouakrim, D., Padget, M., Cassini, A., Cecchini, M.
Worsening epidemiological situation of carbapenemase-producing Enterobacteriaceae in Europe, assessment by national experts from 37 countries, July 2018
Brolund, A., Lagerqvist, N., Byfors, S., Struelens, M.J., Monnet, D.L., Albiger, B., Kohlenberg, A.
Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals - ECDC PPS validation protocol version 3.1.2.
This protocol version is an accompanying document to the ECDC protocol for the point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals version 5.3.